GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Total Equity

CANSF (Willow Biosciences) Total Equity : $-0.35 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Willow Biosciences Total Equity?

Willow Biosciences's total equity for the quarter that ended in Dec. 2024 was $-0.35 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Willow Biosciences Total Equity Historical Data

The historical data trend for Willow Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Total Equity Chart

Willow Biosciences Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.44 23.19 12.05 2.56 -0.35

Willow Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.56 1.14 -0.04 0.14 -0.35

Willow Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Willow Biosciences's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1.747-2.101
=-0.35

Willow Biosciences's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1.747-2.101
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Willow Biosciences Total Equity Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Total Equity
Comparable Companies
XCNQ:STRC.X TSXV:ENTG XCNQ:MGW XCNQ:OVAT XCNQ:PBF XCNQ:PHRX TSXV:LFST XCNQ:RAMM XCNQ:STPH XCNQ:CRCC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
45CN:Germany WLLW:Canada
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Website
https://www.willowbio.com
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.